Autoimmune hemolytic anemia: Clinical and laboratory matters;Auto-immuun-hemolytische anemie: Klinische en laboratoriumaspecten

Nederlands Tijdschrift voor Klinische Chemie en Laboratoriumgeneeskunde

Volumn 31, Issue 4, 2006, Pages 269-274

  Novotny, V M J ^a   Overbeeke, M A M ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Sanquin Diagnostiek   (Netherlands)

Author keywords

Autoimmune haemolytic anaemia; Immune modulation; Transfusion

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; HEMOGLOBIN; IMMUNOGLOBULIN;

AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD TRANSFUSION; DISEASE ACTIVITY; HEMOLYSIS; HUMAN; HYPOXIA; IMMUNOMODULATION; LABORATORY TEST; REVIEW; RISK FACTOR;

EID: 37049017835     PISSN: 15708306     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (8)

1. Dacie J. The immune haemolytic anaemia's: a century of exciting progress in understanding. Br J Haematol 2001;114:770-785.
2. Petz LD, Garraty G. Immune haemolytic anemias, second edition Churcill Livingstone, 2004
3. Roberts NA. Management of Evans syndrome. Br J Haematol 2006; 132: 125-137.
4. Garraty G. Drug induced immune hemolytic anemia's; the last decade. Immunohematol 2004; 20: 138-146.
5. Semple JW, Freedman J. Autoimmune pathogenesis and autoimmune hemolytic anemia. Sem Hematol 2005; 42: 122-130.
6. Petz LD. A physician's guide to transfusion in autoimmune hemolytic anaemia. Br J Haematol 2004; 124: 712-716.
7. Branch DR, Petz LD. Detecting alloantibodies in patients with autoantibodies. Transfusion 1999; 39: 6-10.
8. King KE, Ness PM. Treatment of autoimmune haemolytic anemia. Sem Hematol 2005; 42: 131-136.